Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTAFR | P25105 | 19/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.75 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.75 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.72 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8928418 | 0.92 | PTAFR (0.77) | PTAFRCYP3A4ALOX15OPRK1PDE4D | |
| SCHEMBL9661351 | 0.90 | PTAFR (0.74) | PTAFRCYP3A4ALOX15OPRK1PDE4D | |
| SCHEMBL9661918 | 0.89 | PTAFR (0.73) | PTAFRCYP3A4ALOX15OPRK1PDE4D | |
| SCHEMBL8928557 | 0.89 | PTAFR (0.73) | PTAFRCYP3A4ALOX15OPRK1PDE4D | |
| SCHEMBL9421189 | 0.88 | PTAFR (0.72) | PTAFRCYP3A4ALOX15OPRK1PDE4D | |
| Pyrrole SCHEMBL9661972 | 0.88 | PTAFR (0.72) | PTAFRCYP3A4ALOX15OPRK1PDE4D | |
| SCHEMBL9662085 | 0.88 | PTAFR (0.72) | PTAFRCYP3A4ALOX15OPRK1PDE4D | |
| SCHEMBL9661967 | 0.88 | PTAFR (0.87) | PTAFRCYP3A4ALOX15OPRK1PDE4D | |
| SCHEMBL9654262 | 0.87 | PTAFR (0.71) | PTAFRCYP3A4ALOX15OPRK1PDE4D | |
| SCHEMBL9662015 | 0.87 | PTAFR (0.70) | PTAFRCYP3A4ALOX15OPRK1PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0345931-B1 | CERTAIN PAF ANTAGONIST/ANTIHISTAMINE COMBINATIONS AND METHODS | SCHERING CORPORATION (US) | 1993-01-20 | — | — | EP | claimed |
| EP-0402422-A1 | CERTAIN PAF ANTAGONIST ANTIHISTAMINE COMBINATIONS AND METHODS | SCHERING CORPORATION (US) | 1990-12-19 | — | — | EP | claimed |
| WO-1989010143-A1 | CERTAIN PAF ANTAGONIST ANTIHISTAMINE COMBINATIONS AND METHODS | SCHERING CORPORATION (US) | 1989-11-02 | — | — | WO | claimed |
| US-5334592-A | Administering for allergic reactions; thienotriazolodiazepine compounds | SCHERING CORPORATION (US) | 1994-08-02 | — | — | US | disclosed |
| EP-0345931-B1 | CERTAIN PAF ANTAGONIST/ANTIHISTAMINE COMBINATIONS AND METHODS | SCHERING CORPORATION (US) | 1993-01-20 | — | — | EP | disclosed |
| EP-0402422-A1 | CERTAIN PAF ANTAGONIST ANTIHISTAMINE COMBINATIONS AND METHODS | SCHERING CORPORATION (US) | 1990-12-19 | — | — | EP | disclosed |
| WO-1989010143-A1 | CERTAIN PAF ANTAGONIST ANTIHISTAMINE COMBINATIONS AND METHODS | SCHERING CORPORATION (US) | 1989-11-02 | — | — | WO | disclosed |